News
-
-
-
COMMUNIQUÉ DE PRESSE
Formycon AG and OneSource Specialty Pharma announce strategic Manufacturing Partnership for Biosimilars
Formycon AG and OneSource Specialty Pharma announce strategic manufacturing partnership for biosimilars, enhancing global access to high-quality, affordable biologics. Collaboration between Formycon and OneSource strengthens supply capabilities and manufacturing expertise -
-
-
COMMUNIQUÉ DE PRESSE
Original-Research: Formycon AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research GmbH issued an update on Formycon AG, maintaining a Buy recommendation and reducing the target price to €50. Recent positive developments drive optimism for Formycon's sales of Keytruda biosimilar FYB206 -
-
-
-